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Therapeutic options for metastasized human cancer in current practice remain limited 
and, sadly, there is no cure for metastatic cancer. The typical approach, chemotherapy, 
has both low efficacy due to poor drug solubility, and cytotoxic side effects to healthy 
tissue when delivered indiscriminately. To address both of these issues, we are pursuing 
the use of nanocrystal formulations of current chemotherapeutic agents as delivery 
platforms. Herein, we have studied cellular uptake mechanisms in cancer cells of 
nanocrystals of a chemotherapeutic agent, paclitaxel. Our goal in this study is to 
determine whether the nanocrystals can be taken up via endocytosis, especially when the 
surface is conjugated by ligand molecules that target cancer cells. As such, we cultured 
KB cells with various formulations of paclitaxel nanocrystals, including crystals treated 
with fluorescent dyes for imaging purposes, and with various polymer coatings for 
examining their effect on cellular drug uptake. We examined the incubated cells using 
confocal microscopy in order to identify how the nanocrystals are being taken up.  In 
addition, we measured IC50 values for each nanocrystal formulation. Our results suggest 
the presence of an endocytotic uptake mechanism, as, in cell samples treated with either 
of the conjugated nanocrystals, we see some overlap of the nanocrystal and the lysosome 
imaging agents within the cells. Future work will utilize electron microscopy imaging to 
confirm cellular uptake mechanisms identified here. These data will offer important 
insight for developing novel chemotherapeutic systems that are more effective and safe. 
	  
